-
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life—Results from the Menopause after Cancer (Mac) Study
-
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth
-
Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond
-
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?
Journal Description
Cancers
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Oncology) / CiteScore - Q1 (Oncology)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 17.9 days after submission; acceptance to publication is undertaken in 2.8 days (median values for papers published in this journal in the second half of 2023).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Sections: published in 18 topical sections.
- Companion journals for Cancers include: Radiation and Onco.
Latest Articles
Highly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Deadline: 30 June 2024
Deadline: 7 July 2024
Deadline: 8 August 2024
Deadline: 31 August 2024
Conferences
Special Issues
Deadline: 5 July 2024
Deadline: 15 July 2024
Deadline: 30 July 2024
Deadline: 15 August 2024